The effect of dexmedetomidine and midazoram for analgesic period of spinal anesthesia

The effect of dexmedetomidine and midazoram for analgesic period of spinal anesthesia - The effects of continuous infusion of dexmedetomidine and midazolam on the duration of blockade after spinal anesthesia.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024996

Enrollment

Registered

2016-11-25

Start date

2016-11-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease under spinal anesthesia is selected

Interventions

To enforce the spinal puncture. Local anesthetics to be used as a high specific gravity bupivacaine 13mg. Anesthetic effect, check the anesthesia high every 5 minutes after a high specific gravity bup

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 ASA PS class1-2 2 under 20 years of age or 80 years of age 3 have obtained the written consent

Exclusion criteria

Exclusion criteria: 1 ASA class3-6 2 do not wish to sedation during surgery 3 BMI30 more patient 4 emergency surgery 5 during pregnancy there is a possibility you are breast-feeding or during pregnancy 6 other research investigator or sharing doctor has determined to be inappropriate as a target

Design outcomes

Primary

Measure	Time frame
duration of effect of spinal subarachnoid anesthesia	—

Secondary

Measure	Time frame
sedation level in anesthesia, blood pressure, heart rate, transcutaneous oxygen saturation, BIS (EEG)	—

Countries

Japan

Contacts

Public ContactMariko Watanabe

Tokai Univ. School of medicine Anesthesia department

9j236559@is.icc.u-tokai.ac.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026